DHR — DANAHER CORPORATION (Healthcare >> Diagnostics & Research)
DHR FAQ
What is DHR's P/E ratio?
DANAHER CORPORATION (DHR) currently trades at a P/E ratio of 35.81.
What is DHR's ROE?
DANAHER CORPORATION reports a Return on Equity (ROE) of 6.97%.
What is DHR's dividend yield?
DANAHER CORPORATION offers a dividend yield of 0.76%.
What is DHR's Deepscope Quality Score?
Deepscope rates DHR's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy DHR?
Deepscope's AI Timing Score for DHR is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does DHR belong to?
DANAHER CORPORATION is classified under the Healthcare >> Diagnostics & Research sector on the NYSE exchange.
|
USD 184.30
Price
-2.34
(-1.25%)
Day Change
|
|
|---|
DHR, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
2281
|
| Magic Formula Rank by ROE |
2281
|
| Magic Formula Rank by ROIC |
2633
|
| Price | 184.30 |
| PBV / Sector |
2.49 / -23.44
|
| Earning Per Share | 5.15 |
| PE / Sector |
35.81 / 37.86
|
| PEG or PE/Growth / Sector |
-1.93 / 1.41
|
| Average 1M Daily Value |
724.88 M
|
| Average 1W Daily Value |
652.00 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
54% |
| Ability to Make Profit |
|
62% |
| Return to Investors |
|
41% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:36 |
| Symbol | DHR |
| Name | DANAHER CORPORATION |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NYSE |
| Listed Shares | 707.77 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 132,098.31 / 32,142.66 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701
Phone: 202 828 0850
Website: https://www.danaher.com
Employees: 58,000
Description: Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
Google